Literature DB >> 21207013

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity.

Gregory T Collins1, Yen Nhu-Thi Truong, Beth Levant, Jianyong Chen, Shaomeng Wang, James H Woods.   

Abstract

RATIONALE: Cocaine-induced changes in D(2) receptors have been implicated in the expression of sensitized behavioral responses and addiction-like behaviors; however, the influence of D(3) receptors is less clear.
OBJECTIVES: To characterize the effects of repeated cocaine administration on the sensitivity of rats to D(2)- and D(3)-mediated behaviors, as well as the binding properties of ventral striatal D(2)-like and D(3) receptors.
METHODS: Pramipexole was used to assess the sensitivity of rats to D(3)/D(2) agonist-induced yawning, hypothermia, and locomotor activity, 24 h, 72 h, 10, 21, and 42 days after repeated cocaine or saline administration. The locomotor effects of cocaine (42 day) and the binding properties of ventral striatal D(2)-like and D(3) receptors (24 h and 42 days) were also evaluated.
RESULTS: Cocaine-treated rats displayed an enhanced locomotor response to cocaine, as well as a progressive and persistent leftward/upward shift of the ascending limb (72 h-42 day) and leftward shift of the descending limb (42 days) of the pramipexole-induced yawning dose-response curve. Cocaine treatment also decreased B (max) and K (d) for D(2)-like receptors and increased D(3) receptor binding at 42 days. Cocaine treatment did not change pramipexole-induced hypothermia or locomotor activity or yawning induced by cholinergic or serotonergic agonists.
CONCLUSIONS: These studies suggest that temporal differences exist in the development of cocaine-induced sensitization of D(3) and D(2) receptors, with enhancements of D(3)-mediated behavioral effects observed within 72 h and enhancements of D(2)-mediated behavioral effects apparent 42 days after cocaine. These findings highlight the need to consider changes in D(3) receptor function when thinking about the behavioral plasticity that occurs during abstinence from cocaine use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207013      PMCID: PMC3102773          DOI: 10.1007/s00213-010-2154-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  62 in total

1.  Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments.

Authors:  G D Stanwood; I Lucki; P McGonigle
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

2.  Neuroadaptation. Incubation of cocaine craving after withdrawal.

Authors:  J W Grimm; B T Hope; R A Wise; Y Shaham
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

Review 3.  Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies.

Authors:  L J Vanderschuren; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  2000-08       Impact factor: 4.530

Review 4.  Neuroadaptive effects of active versus passive drug administration in addiction research.

Authors:  Edwin H Jacobs; August B Smit; Taco J de Vries; Anton N M Schoffelmeer
Journal:  Trends Pharmacol Sci       Date:  2003-11       Impact factor: 14.819

5.  Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure.

Authors:  Michael A Nader; James B Daunais; Tonya Moore; Susan H Nader; Rodney J Moore; Hilary R Smith; David P Friedman; Linda J Porrino
Journal:  Neuropsychopharmacology       Date:  2002-07       Impact factor: 7.853

6.  Dopamine receptor binding and quantitative autoradiographic study.

Authors:  Beth Levant
Journal:  Methods Mol Med       Date:  2003

7.  Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization.

Authors:  Taco J De Vries; Anton N M Schoffelmeer; Rob Binnekade; Halfdan Raasø; Louk J M J Vanderschuren
Journal:  Neuropsychopharmacology       Date:  2002-01       Impact factor: 7.853

8.  Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.

Authors:  Mark J Millan; Lisa Maiofiss; Didier Cussac; Valérie Audinot; Jean-A Boutin; Adrian Newman-Tancredi
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

9.  Behavioural sensitization and enhanced dopamine response in the nucleus accumbens after intravenous cocaine self-administration in mice.

Authors:  Agustin Zapata; Vladimir I Chefer; Robert Ator; Toni S Shippenberg; Beatriz A Rocha
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

10.  Evidence for regulation of body temperature in rats by dopamine D2 receptor and possible influence of D1 but not D3 and D4 receptors.

Authors:  F Chaperon; M D Tricklebank; L Unger; H C Neijt
Journal:  Neuropharmacology       Date:  2003-06       Impact factor: 5.250

View more
  21 in total

1.  Dopamine D3 receptor function and cocaine exposure.

Authors:  Brandi L Blaylock; Michael A Nader
Journal:  Neuropsychopharmacology       Date:  2012-01       Impact factor: 7.853

2.  Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.

Authors:  Kurt M Fraser; Joshua L Haight; Eliot L Gardner; Shelly B Flagel
Journal:  Behav Brain Res       Date:  2016-02-22       Impact factor: 3.332

3.  Increased vulnerability to cocaine in mice lacking dopamine D3 receptors.

Authors:  Rui Song; Hai-Ying Zhang; Xia Li; Guo-Hua Bi; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

4.  Crack cocaine use due to dopamine agonist therapy in Parkinson disease.

Authors:  Joseph H Friedman; Victoria Chang
Journal:  Neurology       Date:  2013-05-15       Impact factor: 9.910

5.  Lack of abuse potential in a highly selective dopamine D3 agonist, PF-592,379, in drug self-administration and drug discrimination in rats.

Authors:  Gregory T Collins; Paul Butler; Chris Wayman; Sian Ratcliffe; Paul Gupta; Geoffrey Oberhofer; S Barak Caine
Journal:  Behav Pharmacol       Date:  2012-06       Impact factor: 2.293

Review 6.  Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.

Authors:  Bernard Le Foll; Patricia Di Ciano
Journal:  Eur Neuropsychopharmacol       Date:  2014-09-16       Impact factor: 4.600

7.  Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys.

Authors:  Susan E Martelle; Susan H Nader; Paul W Czoty; William S John; Angela N Duke; Pradeep K Garg; Sudha Garg; Amy H Newman; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2014-05-29       Impact factor: 4.030

8.  Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats.

Authors:  Benjamin D Hobson; Kathryn E Merritt; Ryan K Bachtell
Journal:  Neuropharmacology       Date:  2012-06-28       Impact factor: 5.250

9.  Sensitivity to apomorphine-induced yawning and hypothermia in rats eating standard or high-fat chow.

Authors:  Michelle G Baladi; Yvonne M Thomas; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2011-12-30       Impact factor: 4.530

10.  Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats.

Authors:  Gregory T Collins; Alyssa R Cunningham; Jianyong Chen; Shaomeng Wang; Amy H Newman; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2011-06-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.